NEW BRUNSWICK, N.J. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) today announced that they have entered into a ...

Shockwave Medical specializes in developing and commercializing medical devices using IVL technology for treating calcified plaque in vascular and heart valve diseases. The company has achieved ...

As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund ...

A report surfaced that Johnson & Johnson was in talks to acquire Shockwave, though neither company has confirmed the rumors. An analyst initiated coverage on the stock. Robust results last month have ...

(Reuters) -Johnson & Johnson is in talks to buy medical device maker Shockwave Medical, the Wall Street Journal reported on Tuesday, as the healthcare giant potentially looks to expand its presence in ...

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

Shares of Shockwave Medical SWAV are up almost 15% so far this week. Majority of this gain is likely due to acquisition rumors. According to a report by the Wall Street Journal, Johnson & Johnson JNJ ...

Johnson & Johnson on Friday announced it would acquire heart device firm Shockwave Medical for $13.1 billion. It’s J&J’s second billion-dollar deal in the cardiovascular space in two years, following ...

Shares of Shockwave Medical (NASDAQ: SWAV) were down 9.5% as of 11:35 a.m. ET Tuesday, according to data provided by S&P Global Market Intelligence, after the company announced mixed second-quarter ...